IP Library Granted Patent US 9,333,316
Granted Patent B2
US 9,333,316 · App. 13/475,136 · Granted May 10, 2016

Drug administration controller

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,316
App. No.
13/475,136
Granted
May 10, 2016
Kind
B2
Abstract

A drug administration controller has a sensor that generates a sensor signal to a physiological measurement device, which measures a physiological parameter in response. A control output responsive to the physiological parameter or a metric derived from the physiological parameter causes a drug administration device to affect the treatment of a person, such as by initiating, pausing, halting or adjusting the dosage of drugs administered to the person.

Claims (17)

1. A drug administration method comprising:

receiving, over a period of time, a signal indicative of at least one physiological parameter from a noninvasive optical sensor attached to a patient;

determining, based on the signal, a plurality of measurements of the at least one physiological parameter, each of the plurality of measurements indicative of a value of the at least one physiological parameter at a different time during the period of time;

determining, based on the plurality of measurements, at least one parameter trend for the at least one physiological parameter, the at least one parameter trend indicating a rate at which the at least one physiological parameter is increasing or decreasing over the period of time; and

controlling a drug administration device based at least on one of the at least one parameter trends, wherein the at least one physiological parameter is a measure of blood methemoglobin (HbMet).

2. The drug administration method according to claim 1 , further comprising deriving at least one of a parameter limit, a parameter pattern, or a parameter variability.

3. The drug administration method according to claim 1 , wherein controlling comprises pausing the drug administration device when HbMet is trending upward.

4. The drug administration method according to claim 1 , wherein controlling comprises pausing the drug administration device when HbMet is above a HbMet limit.

5. A drug administration controller comprising:

at least one noninvasive optical sensor that generates, over a period of time, at least one sensor signal in response to a physiological state of a living being;

at least one physiological measurement device configured to:

determine, in response to the at least one sensor signal, a plurality of measurements of at least one physiological parameter, each of the plurality of measurements indicative of a value of the at least one physiological parameter at a different time during the period of time, said at least on physiological parameter including methemoglobin (HbMet); and

determine, based on the plurality of measurements, at least one trend for the at least one physiological parameter, the at least one trend indicating a rate at which the at least one physiological parameter is increasing or decreasing over the period of time;

a rule-based processor that generates a control output in response to the at least one trend; and

a drug administration device responsive to one or more control outputs so as to affect the treatment of the living being including at least one of initiating, pausing, halting or adjusting the dosage of administered drugs.

6. The drug administration controller according to claim 5 , wherein the drug administration device is at least one of a drug infusion device or a medical gas inhalation device.

7. The drug administration controller according to claim 5 , further comprising a sound sensor attached proximate to a neck site so as to measure respiration rate.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Nov 7, 2018
From: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
To: MASIMO CORPORATION; MASIMO AMERICAS, INC.
Reel/Frame 047443/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2016
From: KIANI, MASSI JOE E.
To: MASIMO CORPORATION
Reel/Frame 040063/0099 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 032784 FRAME: 0864. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded May 27, 2014
From: MASIMO AMERICAS, INC.; MASIMO CORPORATION
To: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
Reel/Frame 033032/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2014
From: MASIMO CORPORATION; MASIMO AMERICAS, INC.
To: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
Reel/Frame 032784/0864 →